Moore RG - Search Results

1

PT19c, Another Nonhypercalcemic Vitamin D2 Derivative, Demonstrates Antitumor Efficacy in Epithelial Ovarian and Endometrial Cancer Models.

Kawar N, Maclaughlan S, Horan TC, Uzun A, Lange TS, Kim KK, Hopson R, Singh AP, Sidhu PS, Glass KA, Shaw S, Padbury JF, Vorsa N, Arnold LA, Moore RG, Brard L, Singh RK. Kawar N, et al. Among authors: moore rg. Genes Cancer. 2013 Nov;4(11-12):524-34. doi: 10.1177/1947601913507575. Genes Cancer. 2013. PMID: 24386512 Free PMC article.

2

Inguinal sentinel node dissection versus standard inguinal node dissection in patients with vulvar cancer: A comparison of the size of metastasis detected in inguinal lymph nodes.

Robison K, Steinhoff MM, Granai CO, Brard L, Gajewski W, Moore RG. Robison K, et al. Among authors: moore rg. Gynecol Oncol. 2006 Apr;101(1):24-7. doi: 10.1016/j.ygyno.2005.08.052. Epub 2005 Oct 24. Gynecol Oncol. 2006. PMID: 16246399

3

The effect of total parenteral nutrition on the survival of terminally ill ovarian cancer patients.

Brard L, Weitzen S, Strubel-Lagan SL, Swamy N, Gordinier ME, Moore RG, Granai CO. Brard L, et al. Among authors: moore rg. Gynecol Oncol. 2006 Oct;103(1):176-80. doi: 10.1016/j.ygyno.2006.02.013. Epub 2006 Mar 27. Gynecol Oncol. 2006. PMID: 16564074

4

Isolated sentinel lymph node dissection with conservative management in patients with squamous cell carcinoma of the vulva: a prospective trial.

Moore RG, Robison K, Brown AK, DiSilvestro P, Steinhoff M, Noto R, Brard L, Granai CO. Moore RG, et al. Gynecol Oncol. 2008 Apr;109(1):65-70. doi: 10.1016/j.ygyno.2007.12.027. Epub 2008 Feb 5. Gynecol Oncol. 2008. PMID: 18255128 Clinical Trial.

5

Current state of biomarker development for clinical application in epithelial ovarian cancer.

Moore RG, MacLaughlan S, Bast RC Jr. Moore RG, et al. Gynecol Oncol. 2010 Feb;116(2):240-5. doi: 10.1016/j.ygyno.2009.09.041. Epub 2009 Oct 31. Gynecol Oncol. 2010. PMID: 19879639 Free PMC article. Review.

6

Current clinical use of biomarkers for epithelial ovarian cancer.

Moore RG, Maclaughlan S. Moore RG, et al. Curr Opin Oncol. 2010 Sep;22(5):492-7. doi: 10.1097/CCO.0b013e32833c3351. Curr Opin Oncol. 2010. PMID: 20613519 Review.

7

Tetrathiomolybdate induces doxorubicin sensitivity in resistant tumor cell lines.

Kim KK, Kawar NM, Singh RK, Lange TS, Brard L, Moore RG. Kim KK, et al. Among authors: moore rg. Gynecol Oncol. 2011 Jul;122(1):183-9. doi: 10.1016/j.ygyno.2011.03.035. Epub 2011 May 6. Gynecol Oncol. 2011. PMID: 21529906

8

Organometallic iron(III)-salophene exerts cytotoxic properties in neuroblastoma cells via MAPK activation and ROS generation.

Kim KK, Singh RK, Strongin RM, Moore RG, Brard L, Lange TS. Kim KK, et al. Among authors: moore rg. PLoS One. 2011 Apr 29;6(4):e19049. doi: 10.1371/journal.pone.0019049. PLoS One. 2011. PMID: 21559503 Free PMC article.

9

Evaluation of the first Ergocalciferol-derived, non hypercalcemic anti-cancer agent MT19c in ovarian cancer SKOV-3 cell lines.

Brard L, Lange TS, Robison K, Kim KK, Ara T, McCallum MM, Arnold LA, Moore RG, Singh RK. Brard L, et al. Among authors: moore rg. Gynecol Oncol. 2011 Nov;123(2):370-8. doi: 10.1016/j.ygyno.2011.07.002. Epub 2011 Jul 30. Gynecol Oncol. 2011. PMID: 21803404

10

Description of the cytotoxic effect of a novel drug Abietyl-Isothiocyanate on endometrial cancer cell lines.

Horan TC, Zompa MA, Seto CT, Kim KK, Moore RG, Lange TS. Horan TC, et al. Among authors: moore rg. Invest New Drugs. 2012 Aug;30(4):1460-70. doi: 10.1007/s10637-011-9728-z. Epub 2011 Aug 2. Invest New Drugs. 2012. PMID: 21809024

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

279 results

Search Page

Filters